Patient info Open main menu

Jivi 1000 IU powder and solvent for solution for injection – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine strength:
1000 IU

Patient leaflet - Jivi 1000 IU injection

1. What Jivi is and what it is used for

Jivi contains the active substance damoctocog alfa pegol. It is produced by recombinant technology without addition of any human- or animal-derived components in the manufacturing process. Factor VIII is a protein naturally found in the blood that helps to clot it. The protein in damoctocog alfa pegol has been modified (pegylated) to prolong its action in the body. Jivi is used to treat and prevent bleeding in previously treated adults and adolescents aged from 12 years with haemophilia A (hereditary factor VIII deficiency). It is not for use in children younger than 12 years of age.

2. What you need to know before you use Jivi

Do not use Jivi if you are

R allergic to damoctocog alfa pegol or any of the other

ingredients of this medicine (listed in section 6). R allergic to mouse or hamster proteins.

Warnings and precautions

Talk to your doctor or pharmacist if you have

R tightness in the chest, fall in blood pressure (often shown

by feeling dizzy when getting up quickly), itchy nettle-rash, wheezing, feeling sick or faint. These may be signs of a rare severe sudden allergic reaction to this medicine. Stop

injecting the product immediately and get medical help at once if this occurs.

R bleeding that is not being controlled with your usual dose

of this medicine. Speak with your doctor immediately if this occurs. You may have developed antibodies against factor VIII (inhibitors) or antibodies against polyethylene glycol (PEG). These make Jivi less effective at preventing and controlling bleeding. Your doctor may carry out tests to confirm this and ensure that your Jivi dose provides adequate factor VIII levels. Your doctor may switch you back to your previous factor VIII treatment, if needed. R previously developed factor VIII inhibitors to a different

product.

R heart disease or you are at risk of heart disease. R to use a central venous access device for this medicine. You

may be at risk of device-related complications where the catheter is inserted including:

  • local infections
  • bacteria in the blood
  • a blood clot in the blood vessel

Children

Jivi is not for use in children younger than 12 years of age.

Other medicines and Jivi

Jivi is not known to influence or be influenced by other medicines. Tell your doctor or pharmacist if you are using, have recently used or might use any other medicines.

Pregnancy and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.

Driving and using machines

Jivi has no influence on your ability to drive and use machines.

Jivi contains sodium

This medicine contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’.

3. How to use Jivi

Treatment with Jivi will be started by a doctor who is experienced in the care of patients with haemophilia A. After suitable training patients or carers may be able to give Jivi at home.

Always use this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. The dose of factor VIII units is measured in International Units (IU).

Treatment of bleeding

To treat a bleed, your doctor will calculate and adjust your dose and how often it should be given, depending on factors such as:

R your weight

R the severity of your haemophilia A

R where the bleeding is and how serious it is

R whether you have inhibitors and how high their level is R the factor VIII level that is needed.

Prevention of bleeding

To prevent bleeding your doctor will select an appropriate dose and frequency depending on your need:

R 45–60 IU per kg body weight every 5 days or R 60 IU per kg body weight every 7 days or

R 30–40 IU per kg body weight two times per week.

Laboratory tests

Laboratory tests at suitable intervals help to ensure you always have adequate factor VIII levels. For major surgery in particular, your blood clotting must be closely monitored.

Duration of treatment

Usually Jivi treatment for haemophilia is needed lifelong.

How Jivi is given

Jivi is injected into a vein over 2 to 5 minutes depending on the total volume and your comfort level. The maximum rate is 2.5 mL per minute. Jivi should be used within 3 hours after reconstitution.

How Jivi is prepared for injection

Use only the components (vial adapter, pre-filled syringe containing solvent and venipuncture set) provided with each package of this medicine. Please contact your doctor if these components cannot be used. Do not use if any component of the package is opened or damaged.

The reconstituted product must be filtered by using the vial adapter before injection to remove any possible particles in the solution.

This medicine must not be mixed with other injections. Do not use solutions that are cloudy or contain visible particles. Follow the instructions for use given by your doctor and provided at the end of this leaflet.

If you use more Jivi than you should

Tell your doctor if this occurs. No symptoms of overdose have been reported.

If you forget to use Jivi

Inject your next dose immediately and continue at regular intervals as advised by your doctor.

Do not use a double dose to make up for a forgotten dose.

If you stop using Jivi

Do not stop using this medicine without checking with your doctor.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The most serious side effects are allergic reactions or severe allergic reaction. Stop injecting Jivi immediately and speak to your doctor at once if such reactions occur. The following symptoms could be an early warning of these reactions: R chest tightness/general feeling of being unwell R burning and stinging at the application site R nettle-rash, flushing

R a reduction in blood pressure, which may make you feel

faint upon standing

R feeling sick (nausea)

For patients who have received previous treatment with factor VIII (more than 150 days of treatment) inhibitor antibodies (see section 2) may form uncommonly (less than 1 in 100 patients). If this happens your medicine may stop working properly and you may experience persistent bleeding. If this happens, you should contact your doctor immediately. The following side effects may occur with this medicine:

Very common (may affect more than 1 in 10 people): R headache

Common (may affect up to 1 in 10 people):

R stomach pain

R nausea, vomiting

R fever

R allergic reactions (may present as hives, generalized

urticaria, tightness of the chest, wheezing, shortness of breath, low blood pressure, for early symptoms see above) R local reactions at the injection site such as bleeding under

the skin, intense itching, swelling, burning sensation, temporary redness

R dizziness

R trouble falling asleep

R cough

R rash, skin reddening

Uncommon (may affect up to 1 in 100 people): R FVIII inhibition

R taste disturbance

R flushing

R itching

Reporting of side effects

If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects, you can help provide more information on the safety of this medicine.

5. How to store Jivi

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on labels and cartons. The expiry date refers to the last day of that month.

Store in a refrigerator (2 °C - 8 °C). Do not freeze. Keep the vial and the pre-filled syringe in the outer carton in order to protect from light.

This medicine may be stored at room temperature (up to 25 °C) for up to 6 months when you keep it in its outer carton. If you store it at room temperature it expires after 6 months, or the expiry date if this is earlier.

The new expiry date must be noted on the outer carton when the medicine is removed from the refrigerator.

Do not refrigerate the solution after reconstitution. The reconstituted solution must be used within 3 hours.

Do not use this medicine if you notice any particles or the solution is cloudy.

This medicine is for single use only. Any unused solution must be discarded.

Do not throw away any medicines via wastewater or household waste. Ask your pharmacist or physician how to throw away medicines you no longer use. These measures will help protect the environment.

6. Contents of the pack and other information

What Jivi contains

R The active substance is PEGylated B-domain deleted

recombinant human coagulation factor VIII (damoctocog alfa pegol). Each vial of Jivi contains nominally 250 or 500 or 1000 or 2000 or 3000 IU damoctocog alfa pegol. After reconstitution with the supplied solvent (sterile water for injection), the prepared solutions have the following concentration:

Strength

Concentration after reconstitution

approximately

250 IU(100 IU / mL)
500 IU(200 IU / mL)
1 000 IU(400 IU / mL)
2 000 IU(800 IU / mL)
3 000 IU(1 200 IU / mL)

R The other ingredients are sucrose, histidine, glycine, sodium

chloride (see section 2 “Jivi contains sodium”), calcium chloride dihydrate, polysorbate 80, acetic acid glacial and water for injections.

What Jivi looks like and contents of the pack

Jivi is provided as a powder and solvent for solution for injection. The powder is dry, and white to slightly yellow. The solvent is a clear liquid. After reconstitution the solution is clear. Each single pack of Jivi contains

R a glass vial with powder

R a pre-filled syringe with solvent

R a separate plunger rod

R a vial adapter

R a venipuncture set

Jivi is available in pack sizes of:

R 1 single pack

R 1 multipack with 30 single packs

Not all pack sizes may be marketed.

Marketing Authorisation Holder

Bayer plc

400 South Oak Way

Reading

RG2 6AD

Manufacturer

Bayer AG

Kaiser-Wilhelm-Allee

51368 Leverkusen

Germany

This leaflet was last revised in 10/2023.

Detailed instructions for reconstitution and administration of Jivi

You will need alcohol swabs, gauze pads, plasters and tourniquet. These items are not included in the Jivi package.

  1. 1.

    Wash your hands thoroughly using soap and warm water. 2. Hold an unopened vial and also a syringe in your hands to

    warm it to a comfortable temperature (do not exceed 37 °C). 3. Remove the protective cap from the vial (A).

    Wipe the rubber stopper on the vial with an alcohol swab and allow the stopper to air dry before use.

  2. 4.

    Place the powder vial on a firm, non-slip

    surface. Peel off the paper cover on the plastic housing of the vial adapter. Do not remove the adapter from the plastic housing. Holding the adapter housing, place over the powder vial and firmly press down (B). The adapter will snap over the vial cap. Do not remove the adapter housing at this point.

  3. 5.

    Hold the pre-filled syringe with solvent

    upright. Grasp the plunger rod as per the

    picture and attach the rod by turning it firmly clockwise into the threaded stopper (C).

  4. 6.

    Holding the syringe by the barrel, snap the

    syringe cap off the tip (D). Do not touch the syringe tip with your hand or any surface. Set the syringe aside for further use.

  5. 7.

    Now remove and discard the adapter

    housing (E).

  6. 8.

    Attach the pre-filled syringe to the threaded

    vial adapter by turning clockwise (F).

  7. 9.

    Inject the solvent by slowly pushing down on

    the plunger rod (G).

    1. 10. Swirl vial gently until all the powder is dissolved (H). Do not shake the vial. Be sure that the powder is completely dissolved. Look to check there are no particles or discoloration before you use the solution. Do not use solutions containing visible particles or that are cloudy.
    2. 11. Hold the vial on the end above the vial adapter and syringe (I). Fill the syringe by drawing the plunger out slowly and smoothly. Ensure that the full content of the vial is drawn into the syringe. Hold the syringe upright and push the plunger until no air is left in the syringe.
    3. 12. Apply a tourniquet to your arm.
    4. 13. Determine the point of injection and clean the skin. 14. Puncture the vein and secure the venipuncture set with a plaster.
    5. 15. Holding the vial adapter in place, remove the syringe from the vial adapter (the adapter should remain attached to the vial). Attach the syringe to the venipuncture set (J). Ensure that no blood enters the syringe
    6. 16. Remove tourniquet.
    7. 17. Inject the solution into a vein over 2 to 5 minutes, keeping an eye on the position of the needle. The speed of injection should be based on your comfort, but should not be faster than 2.5 mL per minute.
    8. 18. If a further dose is needed, use a new syringe with the powder reconstituted as described above.
    9. 19. If no further dose is required, remove the venipuncture set and syringe. Hold a pad firmly over the injection site on your outstretched arm for about 2 minutes. Finally, apply a small pressure dressing to the injection site and consider if a plaster is necessary.
    10. 20.

      It is recommended that every time you use Jivi, you note down the name and the batch number of the product. 21. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist or physician how to throw away medicines you no longer use. These measures will help protect the environment

      B

      288x630-16855_15923

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PLGB 00010/0682

Last revision stated in the text: October 2023 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Jivi 1000 IU injection

Strength 1000 IU
Pharmaceutical form Powder: solid, white to slightly yellow.
Solvent: clear solution.
Excipients Sucrose, Histidine, Glycine, Sodium chloride, Calcium chloride dihydrate, Polysorbate 80, Acetic acid, glacial (for pH adjustment), Solvent, Water for injections
Shelf life Unopened vial
2 years.
Reconstituted solution
The chemical and physical in-use stability after reconstitution has been demonstrated for 3 hours at room temperature. Do not refrigerate after reconstitution.
From a microbiological point of view the product should be used immediately after reconstitution. If not used immediately, the in-use storage times and conditions prior to use are the responsibility of the user.
Storage Store in a refrigerator (2 °C - 8 °C).
Do not freeze.
Keep the vial and the pre-filled syringe in the outer carton in order to protect from light.
Within its overall shelf life of 2 years, the product (when kept in its outer carton) may be stored at up to 25 °C for a limited period of 6 months. The end date of the 6 month storage period at a temperature up to 25 °C should be recorded on the product carton. This date should never exceed the expiry date printed on the outer carton. At the end of this period the product should not be put back in the refrigerator, but should be used or discarded.
For storage conditions after reconstitution of the medicinal product, see section 6.3.
Drug group (ATC) Antihaemorrhagics: blood coagulation factor VIII
  1. B Blood and blood forming organ drugs
    1. B02 Antihemorrhagics
      1. B02B Vitamin K and other hemostatics
        1. B02BD Blood coagulation factors
          1. B02BD02 coagulation factor VIII
Marketing authorisation PLGB 00010/0682 (first authorised 23 June 2023)
Marketing authorisation holder Bayer plc

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.